Enterococcal infection.
This article describes enterococci bacteria and the measures related to glycopeptide-resistant enterococci, including screening, treatment and management, antibiotic prescribing and infection control.
Gould
Dinah
D
School of Nursing and Midwifery, City University, London. d.gould@city.ac.uk
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004196:Disease Outbreaks / Q000517:prevention & control / Q000706:statistics & numerical data; D011307:Drug Prescriptions; D016983:Enterococcus; D016908:Gram-Positive Bacterial Infections / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology; D017053:Infection Control / Q000458:organization & administration*; D008403:Mass Screening; D008826:Microbial Sensitivity Tests; D009730:Nursing Assessment; D018570:Risk Assessment; D006113:United Kingdom / Q000453:epidemiology; D020713:Vancomycin Resistance
D000900:Anti-Bacterial Agents